Omega Medical Imaging is excited to showcase their EP Artificial Intelligence Fluoroscopy Imaging System at the 14th Annual International Symposium on Ventricular Arrhythmias. This course will be held at Hyatt at the Bellevue in Philadelphia, Pennsylvania, Friday October 11th through Saturday, October 12th . The course is hosted by the Department of Medicine, Division of Cardiology, University of Pennsylvania Health System, Philadelphia, PA and the Division of Cardiology, The Mount Sinai Hospital, New York, NY.
The purpose of this educational activity is to provide a current review of new information on the basic pathophysiology of ventricular arrhythmias. It is also designed to provide an in-depth understanding of the various management strategies that are currently being developed for the management of ventricular arrhythmias in various disease states, including non-pharmacologic therapies such as implantable device therapy and advances in catheter ablation techniques.
Omega Medical Imaging launches FluoroShield™ the first AI enabled Radiation Reduction solution yearly this year. The U.S. Food and Drug Administration granted Omega Medical Imaging clearance through the 510(k) process. The Artificial Intelligence Fluoroscopy (AIF) imaging systems reduces radiation exposure to patients and staff up to ~84%. Learn more.
For more information on the event please visit:
If you are attending, be sure to stop by the exhibitor area and see us!
About Omega Medical Imaging
Since 1991 Omega’s engineers, designers, craftsmen and technicians have been building the most reliable and technically advanced Fluoroscopy imaging systems for Interventional Cardiology, IR, and Interventional Endoscopy and now Artificial Intelligence Fluorsocopy (AIF) Systems for Interventional procedures. Omega is the only manufacturer in the world who specializes in systems designed from the ground up for special therapeutic procedures. Our list of growing references includes prestigious physicians, healthcare systems, and providers around the world.